Hydroxychloroquine, and old acquaintance that gained strength in the pandemic.
As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges faced to date, even more so when the use of medicines that were already known and perhaps forgotten by most of the medical community, but which were part of the rheumatologist's daily routine, was proposed...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Panamerican League of Associations of Rheumatology (PANLAR)
2020-09-01
|
| Edice: | Global Rheumatology |
| Témata: | |
| On-line přístup: | https://globalrheumpanlar.org/podcast/hidroxicloroquina-una-vieja-conocida-que-tomo-fuerza-en-la-pandemia-384?language=en |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|